Fluvoxamine is a selective serotonin reuptake inhibitor used for obsessive compulsive disorder. It works by blocking the serotonin transporter so that serotonin remains longer in the brain. The increased serotonin activity influences neural pathways that regulate mood and repetitive thoughts. This pharmacological action leads to a reduction in compulsive behaviors and associated distress. The drug is taken orally and its half life supports once daily dosing in many patients. Selectivity for the serotonin transporter distinguishes it from non selective reuptake blockers. Overall it provides a therapeutic option for certain anxiety related conditions when used as intended.

Fluvoxamine is a selective serotonin reuptake inhibitor used primarily in the treatment of major depressive disorder and obsessive compulsive disorder. It functions by selectively inhibiting the serotonin transporter, thereby preventing the reabsorption of serotonin into presynaptic neurons. This inhibition increases extracellular serotonin levels, which enhances serotonergic neurotransmission throughout the brain. The heightened serotonergic activity contributes to improved mood regulation, reduced anxiety, and decreased compulsive behaviors. Fluvoxamine exhibits a longer half life than many other ssris, which allows for once daily dosing and more stable plasma concentrations. Its metabolic pathway involves oxidation by the cytochrome p450 enzyme cyp1a2 and inhibition of cyp2d6 leading to potential drug interactions. Overall, the medication achieves its therapeutic effect through sustained elevation of serotonin availability and downstream neurochemical modulation.

Fluvoxamine may cause nausea, headache, and insomnia in some individuals. It can also lead to increased anxiety or restlessness particularly during the early weeks of treatment. Some patients experience sexual dysfunction such as decreased libido or difficulty achieving orgasm. Weight changes including modest gain or loss have been reported. The drug may interact with certain foods causing mild gastrointestinal discomfort. Rarely it can result in dizziness or mild fatigue that usually resolves with continued use.

Fluvoxamine may cause nausea, insomnia, or drowsiness in some patients. Headache, dry mouth, and sexual dysfunction are also reported side effects. Some individuals experience increased sweating, gastrointestinal disturbances, or tremor. In certain cases, the medication can lead to heightened anxiety, agitation, or mood swings. Rarely, serotonin syndrome may occur when combined with other serotonergic agents. These effects are generally mild to moderate and often improve with continued use.